Showing 24 of 24 results

BID Initiative
The BID Learning Network recently held a webinar called "Successful implementation of a Health information Software." In this webinar, the speakers shared Mali’s experience implementing health...
PATH
This fact sheet describes PATH’s efforts to eliminate meningococcal meningitis epidemics from Africa, once and for all. It covers work across meningitis projects, including the development and...
Caroline L Trotter et al.
Background: In preparation for the introduction of MenAfriVac, a meningococcal group A conjugate vaccine developed for the African meningitis belt, an enhanced meningitis surveillance network was...
Mahamadou S Sissoko et al.
Background: Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria sporozoite vaccine that has been reported to be safe and protective against P...
Mable Carole Tevi-Benissan et al.
Background Significant progress has been made to increase access to vaccines in Africa since the 1974 launch of the Expanded Programme on Immunization (EPI). Successes include the introduction of...
Milagritos D Tapia et al.
Background Despite the heightened risk of serious influenza during infancy, vaccination is not recommended in infants younger than 6 months. We aimed to assess the safety, immunogenicity, and...
Abdel Karim Koumaré, Drissa Traore, Fatouma Haidara, Filifing Sissoko, Issa Traoré, Sékou Dramé, Karim Sangaré, Karim Diakité, Bréhima Coulibaly, Birama Togola, Aguissa Maïga
In 1986, the Government of Mali launched its Expanded Program on Immunization (EPI) with the goal of vaccinating, within five years, 80% of all children under the age of five against six target...
Minetti
Vaccination coverage surveys - Publication abstract: BACKGROUND: Estimation of vaccination coverage at the local level is essential to identify communities that may require additional support....
World Health Organization (WHO)
This report highlights the achievements made in expanding access to vaccines in Africa and discusses some of the remaining challenges to achieving universal access to vaccines. The timing of this...
Alassane Dicko, Ousmane B Toure, Issaka Sagara, Mariam Traore, Sidy O Toure, Mahamadou S Sissoko, Alpha T Diallo, Christophe Rogier, Roger Salomon, Alexandra de Sousa, Ogobara K Doumbo
This study shows that high coverage of the IPTi can be obtained when the strategy is implemented using routine health services and implementation resulted in a significant increase in coverage of EPI...
BID
The BLN is a platform for peer learning and information exchange intended to enable strong collaborative links between peers from different countries in support of improved data...
Ryman TK et al.
Communities generally supported integration, and integrated services may have the potential to increase service utilization and possibly even reduce the stigma of certain services. Some concerns...
World Health Organization (WHO)
This report, prepared by the Secretariat for the Decade of Vaccines Global Vaccine Action Plan, serves as the basis for the independent review. As was the case in 2013 and 2014, this report reviews...
Kathleen Tiffay et al.
The development, through a public–private partnership, of a safe, effective, and affordable vaccine for sub-Saharan Africa, PsA-TT, offers a new paradigm for the development of vaccines...
M. Teresa Aguado et al.
In June 2001, BMGF awarded a grant of US$70 million to create the Meningitis Vaccine Project (MVP) as a partnership between PATH and WHO, with the specific goal of developing an affordable MenA...
Helen E.D. Burchett et al.
The study found that new vaccines were viewed positively and seemed to integrate well into existing health systems. The introductions were found to have had no impact on many elements within the...
Sandra Mounier-Jack et al.
The study seeks to evaluate the impact of the meningococcal A (MenA) vaccine introduction in Mali through mass campaigns on the routine immunization program and the wider health system.It concludes...
The 11th International Rotavirus Symposium brought together over 650 people from 56 countries in New Delhi, India, from 3-5 September, 2014 to examine new surveillance data and studies demonstrating...
Estimation of vaccination coverage at the local level is essential to identify communities that may require additional support. Cluster surveys can be used in resource-poor settings, when population...
Arthur L Caplan
The first true epidemic of Ebola led to widespread panic. The virus appeared in so many countries in 2014—including Guinea, Liberia, Mali, Nigeria, Senegal, Sierra Leone, Spain, and the USA—that...
S Torres-Rueda, HED Burchett, UK Griffiths, P Ongolo-Zogo, J Edengue, Y Kitaw, M Molla, L Gelmon, W Onyango-Ouma, M Konate, S Mounier-Jack
Abstract Background: Pneumonia is a main cause of under-five mortality in low-income settings. The pneumococcal conjugate vaccine (PCV) has been introduced in many countries as a tool in the...
Lode Schuerman, Dorota Borys, Ana Strezova, Juan Pablo Yarzabal, Nancy François, Fakrudeen Shafi, Ogobara Doumbo, Aminata Diallo, Amagana Dolo, Gaoussou Santara, Almahamoudou Mahamar, Youssoufa Sidibe, Amadou Barry, Yahia Dicko, Alassane Dicko
Pneumonia is still the leading cause of death among African children with pneumococcal serotypes 1 and 5 being dominant in the below 5 y of age group. The present study assessed the safety,...